David M. Knott’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

David M. Knott’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$101K	Hold	800	–	–	0.04%	119
2021 Q2	$108K	Sell	800 -3,000	-79%	-$394K	0.04%	116
2021 Q1	$515K	Buy	+3,800	New	+$569K	0.22%	68

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

David M. Knott's XBI Position: Q3 2021 in Review

David M. Knott held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2021 at 800 shares worth $101K. The position accounts for 0.04% of the portfolio, ranked #119.

David M. Knott first reported a position in XBI in Q1 2021 and has held it in 3 quarters since. The position peaked at $515K in Q1 2021. 635 funds tracked by Wall St. Rank hold XBI as of Q3 2021.

David M. Knott held 800 shares of State Street SPDR S&P Biotech ETF worth $101K as of Q3 2021.
David M. Knott left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2021.
State Street SPDR S&P Biotech ETF made up 0.04% of David M. Knott's portfolio in Q3 2021, its #119 holding.
David M. Knott first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and has held it in 3 quarters since.
David M. Knott's State Street SPDR S&P Biotech ETF position peaked at $515K in Q1 2021.
635 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.